1 thought on “Why does the small glass bottle of Shandong Pharmacy vs skyrocketed?”

  1. author | Ding Jingzhi
    about 7 minutes to read

    The overseas new crown virus is still raging, and local Beijing, Dalian, Xinjiang and other places broke out. The listing of the new crown vaccine made the world look forward to it. On July 21, the new crown vaccine stock Kangxino Biological Announcement, its research and development reorganized new coronary virus vaccine (adenovirus carrier) clinical trial II research results were published in Liuye knife. The research and development of the new crown vaccine has obtained a key breakthrough, confirming its safety and reliability, and the upstream and downstream of the vaccine industry chain is constantly triggering investors.
    If countries have prepared for the new crown vaccine before listing. The Ministry of Industry and Information Technology of the Ministry of Industry and Information Technology explores the supply and reserves of the new crown vaccine and related packaging materials. On July 20, Pfizer and BIONTECH signed a purchase agreement with the British government of 30 million doses of new crown vaccines. On July 22, the US Department of Health and Public Services (HHS) also officially announced an agreement with 600 million vaccines with the Ministry of Health and Public Services (HHS).
    The stock price of new crown vaccine research and development enterprises such as Zhifei Biology, Watson Biology, Fosun Pharmaceuticals has risen, and the concept of medicinal glass bottle used for vaccine packaging has also begun to enter the investor vision. Related concept stocks include domestic pharmaceutical glass leading companies in Shandong Pharmaceutical Glass (600529.SH) and medicinal glass producers, Zhengchuan (603976.SH).
    As of July 31, Shandong Yaoqi rose from 28.03 yuan to 71.1 yuan at the beginning of the year, an increase of 159%; Zhengchuan rose from 17.77 yuan to 92.88 yuan, an increase of 436%.
    Am small glass bottle, why cause investors to scramble to hype?

    The opportunity for small industries
    The borosilicon medicinal glass has become a clear future for the medicinal glass market.

    On July 4, Professor Zhang Wenhong said that the output of glass bottle installed with vaccines is more difficult than vaccines. Not only did this problem in China, as early as April, a professor at the University of Oxford University said that there are currently only 200 million vaccine glass bottles in the world. The output of vaccine glass bottle has become the problem of “stuck neck” of the terminal audience.
    This has subverted investors’ cognition. The medicinal glass bottles that investors have been ignored before were so high in gold content.
    What is the gold content of medicinal glass bottles?
    The medicinal glass bottle quality from low to high is sodium and calcium glass bottle, low borosilicon glass bottle and medium borosilicon glass bottle. The new crown vaccine needs to be stored in the highest -quality borosilicon glass bottle. Compared with sodium and lipstick glass bottle and low borosilica, medium boron -silicon material can keep the vaccine stable state.
    If drugs will be affected by temperature, humidity, air, light, microorganisms, etc., the stability of the drug will change. Neutral borosilicon glass will Infusion speed is far better than borosilicon glass. Under the long time of drugs, the glass bottle will not be precipitated, nor will it cause pH changes. It has excellent chemical stability and thermal stability. Therefore, the technical threshold for borosilicon glass bottle is high. The market segment has long been controlled by three major overseas companies including Schott, the United States, and Japan.
    Then domestic replacement in the field of medicinal glass, in the past five years, my country’s pharmaceutical glass market has a rise in scale as a whole. In 2018, it reached 21.94 billion yuan, accounting for about 20%of the pharmaceutical packaging industry.
    Since 2017, the consistency evaluation of the drug injection of drugs is on the agenda, and the packaging materials and containers of direct contact drugs used in the injection should meet the packaging standards promulgated by the General Administration. It is not recommended to use low borosilized glass and Sodium and salt glass.
    . The current situation of our country is mostly low -end sodium and calcium glass and low borosilicon glass for drug packaging. Foreign pharmaceutical companies generally use borosilicon glass bottles. The reason for the first borosilicon is high, and the second is difficult to control production stability.
    Minic drugs in China prevail, and costs have become key factor. Even the supporting glass bottles have become part of cost control. Most of them are used for low borosilicon or sodium and liquid glass bottle. Smilly glass bottle. However, my country’s pharmaceutical industry is transforming and upgrading from generic drugs to innovative drugs.
    In from FROST

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top
Scroll to Top